Home/Filings/4/A/0000950170-24-004226
4/A//SEC Filing

Wood Steven D 4/A

Accession 0000950170-24-004226

CIK 0001262104other

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 4:00 PM ET

Size

8.2 KB

Accession

0000950170-24-004226

Insider Transaction Report

Form 4/AAmended
Period: 2023-12-18
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-12-18+6,7006,700 total
    Exercise: $6.19Exp: 2033-12-18Common Stock (6,700 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-12-18+10,00010,000 total
    Exercise: $6.19Exp: 2033-12-18Common Stock (10,000 underlying)
Footnotes (2)
  • [F1]Such option shall be vested and exercisable with respect to 12.5% of the shares on the date of grant and the remainder of the option will vest and become exercisable in equal monthly amounts of 12.5% of the shares subject to the option, beginning on the first day of each calendar month following the date of grant (January 1, 2024) and continuing through July 1, 2024 with full vesting on July 1, 2024, subject to continued service through the applicable vesting date.
  • [F2]Such option shall vest and become exercisable in 36 equal monthly installments, with the first installment vesting on the one-month anniversary of the date of grant, subject to continued service through the applicable vesting date.

Documents

1 file

Issuer

MEI Pharma, Inc.

CIK 0001262104

Entity typeother

Related Parties

1
  • filerCIK 0002001007

Filing Metadata

Form type
4/A
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 4:00 PM ET
Size
8.2 KB